Invitation to submit a proposal by direct adjustment for the acquisition of A5356 - Fluocinolone acetonide [190 μg; intravitreal implant; applicator]

This tender is an invitation for proposals through a direct adjustment process for the procurement of A5356, specifically Fluocinolone acetonide. The product is specified as having a dosage of 190 micrograms and is intended for intravitreal implantation, supplied with an applicator. The direct adjustment method suggests a streamlined procurement process, likely due to specific circumstances or a pre-identified supplier. The focus is on acquiring a particular pharmaceutical product with precise specifications for ophthalmic use. Further details regarding the exact quantity, delivery timelines, and evaluation criteria would be available in the full tender documentation. This acquisition is crucial for medical treatments requiring this specific corticosteroid implant for ocular conditions.

This is a supplies contract in the health and medical services, Monitoring Evaluation and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 31,272.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.